SF-36 Summary Scores: Are Physical and Mental Health Truly Distinct?

Medical Care

Volumn 36, Issue 4, 1998, Pages 567-572

  Simon, Gregory E ^a,c   Revicki, Dennis A ^b   Grothaus, Louis ^a   Vonkorff, Michael ^a  

^a CENTER FOR HEALTH STUDIES   (United States)

^b MEDTAP International   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Depression; Functional status; Quality of life; SF 36

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; DEPRESSION; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; QUALITY OF LIFE; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; QUALITY OF LIFE; TREATMENT OUTCOME; UNITED STATES; WASHINGTON;

EID: 0032037586     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199804000-00012     Document Type: Article

References (17)

1. Bergner M, Bobbitt RA, Carter WB, Gilson S. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981;19:787.
2. Ware J, Sherbourne C. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473.
3. Ware J, Kosinski M, Keller SD. SF-36 Physical and Mental Component Summary Scales: A user's manual. Boston, MA: The Health Institute, New England Medical Center, 1994.
4. Ware J, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 Health Profile and Summary Measures: Summary of results from the Medical Outcomes Study. Med Care 1995;33:AS264.
5. Simon G, Wagner E, VonKorff M. Cost-effec tiveness comparisons using "real world" randomized trials: The case of new antidepressant drugs. J Clin Epidemiol 1995;48:363.
6. Simon G, VonKorff M, Heiligenstein JH, et al. Initial antidepressant selection in primary care: Effectiveness and cost of fluoxetine versus tricyclic antidepressants. JAMA 1996;275:1897.
7. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56.
8. Williams JBW. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiat 1988;45:742.
9. Revicki D, Genduso LA, Hamilton SL, Martin C, Reblando J, Tran PV. Quality of life outcomes for olanzapine and haloperidol treatment for schizophrenia and related psychotic disorders. Presented at the American Psychiatric Association 149th Annual Meeting; May 5-9, 1996; New York, NY.
10. Katon W, Lin E, VonKorff M, Russo J, Lipscomb P, Bush T. Somatization: A spectrum of severity. Am J Psychiat 1991;148:34.
11. Simon G, VonKorff M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area Study. Am J Psychiatry 1991;148:1494.
12. Wells K, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988;145:976.
13. Vazquez-Barquero J, Diez-Manrique JF, Pena-Martin C, et al. A community mental health survey in Cantabria: A general description of morbidity. Psychol Med 1987;17:227.
14. Wells K, Stewart A, Hays R, et al. The functioning and well-being of depressed patients: Results from the Medical Outcome Study. JAMA 1989;262:914.
15. Hays R, Stewart AL. The structure of self-reported health in chronic disease patients. Psychol Assess 1990;2:22.
16. Ware J, Davies-Avery A, Brook RH. Conceptualization and measurement of health for adults in the Health Insurance Study. Vol VI. Analysis of relationships among health status measures. Santa Monica, CA: RAND Corporation, 1980.
17. Hall A, Epstein AM, McNeil BJ. Multidimensionality of health status in an elderly population: Construct validity of a measurement battery. Med Care 1989;27:S168.